HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Weekly Recap

Each week on Saturday morning, the NeurologyLive News Network puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

Aquatic Therapy Improves MS Fatigue, MS Disease Pathology Not Defined by Courses, Rituximab Shows Positive Effect in Myasthenia Gravis

November 26, 2022

Neurology News Network for the week ending November 26, 2022. [WATCH TIME: 4 minutes]

Positive Results of STK-001 in Dravet, Zavegepant Meets Primary End Points, FDA Accepts NDA of Zilucoplan for Myasthenia Gravis

November 19, 2022

Neurology News Network for the week ending November 19, 2022. [WATCH TIME: 3 minutes]

FDA Rejects BLA for NurOwn, Simvastatin Futile as DMT for Parkinson, Music Potentially Improves Insomnia Symptoms

November 12, 2022

Neurology News Network for the week ending November 12, 2022. [WATCH TIME: 4 minutes]

Poor Sleep Associated With Cannabis and Alcohol Use, Dietary Approaches in MS, Noninvasive Brain Stimulation Effective in Alzheimer

November 05, 2022

Neurology News Network for the week ending November 5, 2022. [WATCH TIME: 3 minutes]

Apitegromab Improves Quality of Life in SMA, ARB Therapy Leads to Lowered Epilepsy Risk, Donanemab Reduces Alzheimer-Related Plasma Biomarkers

October 29, 2022

Neurology News Network for the week ending October 28, 2022. [WATCH TIME: 4 minutes]

Positive Interim Report on Fosgonimeton, Lower ASPECTS Scores Impact Efficacy of EVT, FDA Extends Review of Tofersen

October 22, 2022

Neurology News Network for the week ending October 22, 2022. [WATCH TIME: 4 minutes]

Phase 3 LIGHTHOUSE Study Initiated, Trend Toward ASMs With Lower Teratogenic Risk, Rituximab Effects on NMOSD, MOGAD

October 15, 2022

Neurology News Network for the week ending October 15, 2022. [WATCH TIME: 3 minutes]

Ublituximab Outperforms Teriflunomide on ARRs, CNM-Au8 Fails HEALEY ALS Trial, Benefits of Aerobic Exercise in Multiple Sclerosis

October 08, 2022

Neurology News Network for the week ending October 8, 2022. [WATCH TIME: 3 minutes]

Verdiperstat Fails ALS Study, Lecanemab Shines in Latest Phase 3 Findings, Ofatumumab Continues Superiority Over Teriflunomide

October 01, 2022

Neurology News Network for the week ending October 1, 2022. [WATCH TIME: 4 minutes]

Rituximab as Initial gMG Treatment, WVE-003 Proves Positive in HD, and Incidence of Guillian-Barré After COVID-19 Vaccination

September 24, 2022

Neurology News Network for the week ending September 24, 2022. [WATCH TIME: 4 minutes]